Ara
Toplam kayıt 16, listelenen: 11-16
Empiric 131I treatment of high thyroglobulin levels in differentiated thyroid carcinoma after remnant ablation
(Acta Medica Mediterranea, 2014)
Aim: The objective of this study is to establish the efficacy of empiric I-131 treatment (EIT) given for patients whose thyroglobulin(Tg) levels remained high after ablative I-131 treatment (AIT). Methods: Fifty-six patients ...
The evaluation of exposure to hepatitis A virus in HBsAg-positive persons: A multicentre study from Turkey
(Journal of Pure and Applied Microbiology, 2014)
Chronic hepatitis B is a major public health problem in our country. Hepatitis A vaccination in HBV carriers who did not encounter with Hepatitis A virus is also significant. We aimed to evaluate the rate of exposure to ...
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
(Turkiye Klinikleri, 2022)
Background/aim: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in ...
Effect of Direct-acting Oral Anticoagulants and Warfarin on Hospital Outcomes in Upper Gastrointestinal Bleeding
(College of Physicians and Surgeons Pakistan, 2022)
Objective: To evaluate the comparison of direct-acting oral anticoagulants (DOACs) and warfarin for their effects on major bleeding and hospital outcomes in patients with acute nonvariceal upper gastrointestinal bleeding ...
Visceral to subcutaneous fat ratio predicts short-term mortality in patients with Covid 19. A multicenter study
(British Institute of Radiology, 2023)
Objective: To evaluate the association of body composition parameters with outcomes in Covid-19. Methods: 173 patients hospitalized for Covid-19 infection in 6 European centers were included in this retrospective study. ...
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment
(Turkish Neuropsychiatric Society, 2023)
Introduction: Fingolimod is the first oral immunomodulatory treatment used as secondary care therapy in the treatment of multiple sclerosis for the last 10 years. The objective of our study is to reveal the experiences of ...